Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Renal Artery Stenosis | Research article

Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-study

Authors: Darren Green, Diana Vassallo, Kelly Handley, Natalie Ives, Keith Wheatley, Constantina Chrysochou, Janet Hegarty, Julian Wright, Jon Moss, Rajan K. Patel, Chris Deighan, John Webster, Peter Rowe, Sue Carr, Jenny Cross, Jamie O’Driscoll, Raj Sharma, Patrick Mark, Philip A. Kalra

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

The ASTRAL trial showed no difference in clinical outcomes between medical therapy and revascularization for atherosclerotic renal vascular disease (ARVD). Here we report a sub-study using echocardiography to assess differences in cardiac structure and function at 12 months.

Methods

ASTRAL patients from 7 participating centres underwent echocardiography at baseline and 12 months after randomisation. Changes in left ventricular ejection fraction (LVEF), left ventricular mass (LVM), left atrial diameter (LAD), aortic root diameter (AoRD), E:A, and E deceleration time (EDT) were compared between study arms. Analyses were performed using t-tests and multivariate linear regression.

Results

Ninety two patients were included (50 medical versus 42 revascularization). There was no difference between arms in any baseline echocardiographic parameter. Comparisons of longitudinal changes in echocardiographic measurements were: δLVEF medical 0.8 ± 8.7% versus revascularization − 2.8 ± 6.8% (p = 0.05), δLVM − 2.9 ± 33 versus − 1.7 ± 39 g (p = 0.9), δLAD 0.1 ± 0.4 versus 0.01 ± 0.5 cm (p = 0.3), δAoRD 0.002 ± 0.3 versus 0.06 ± 0.3 cm (p = 0.4), δE:A − 0.0005 ± 0.6 versus 0.03 ± 0.7 (p = 0.8), δEDT − 1.1 ± 55.5 versus − 9.0 ± 70.2 ms (p = 0.6). In multivariate models, there were no differences between treatment groups for any parameter at 12 months. Likewise, change in blood pressure did not differ between arms (mean δsystolic blood pressure medical 0 mmHg [range − 56 to + 54], revascularization − 3 mmHg [− 61 to + 59], p = 0.60).

Conclusions

This sub-study did not show any significant differences in cardiac structure and function accompanying renal revascularization in ASTRAL. Limitations include the small sample size, the relative insensitivity of echocardiography, and the fact that a large proportion of ASTRAL patient population had only modest renal artery stenosis as described in the main study.
Literature
4.
go back to reference Zeller T, Rastan A, Schwarzwalder U, et al. Regression of left ventricular hypertrophy following stenting of renal artery stenosis. J Endovasc Ther. 2007;14(2):189–97 doi:1526-6028-14-2-189 [pii]\r10.1583/1545-1550(2007)14[189,ROLVHF]2.0.CO;2.CrossRef Zeller T, Rastan A, Schwarzwalder U, et al. Regression of left ventricular hypertrophy following stenting of renal artery stenosis. J Endovasc Ther. 2007;14(2):189–97 doi:1526-6028-14-2-189 [pii]\r10.1583/1545-1550(2007)14[189,ROLVHF]2.0.CO;2.CrossRef
5.
go back to reference Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953–62.CrossRef Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953–62.CrossRef
8.
go back to reference Missouris C, Buckenham T, Vallance P, MacGregor G. Renal artery stenosis masquerading as congestive heart failure. Lancet. 1993;341(8859):1521–2.CrossRef Missouris C, Buckenham T, Vallance P, MacGregor G. Renal artery stenosis masquerading as congestive heart failure. Lancet. 1993;341(8859):1521–2.CrossRef
10.
go back to reference Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery,⁎ so. J Am Coll Cardiol. 2006;47(6):e1–e192. https://doi.org/10.1016/j.jacc.2006.02.024.CrossRef Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery,⁎ so. J Am Coll Cardiol. 2006;47(6):e1–e192. https://​doi.​org/​10.​1016/​j.​jacc.​2006.​02.​024.CrossRef
11.
go back to reference Ritchie J, Green D, Chrysochou C, Chalmers N, Foley RN. Kalra P a. high-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization. Am J Kidney Dis. 2014;63(2):186–97.CrossRef Ritchie J, Green D, Chrysochou C, Chalmers N, Foley RN. Kalra P a. high-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization. Am J Kidney Dis. 2014;63(2):186–97.CrossRef
14.
go back to reference Schiller N, Shah P, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional EchocardiogramsRecommendations for quantitation of th. J Am Soc Echocardiogr. 1989;2(5):358–67.CrossRef Schiller N, Shah P, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional EchocardiogramsRecommendations for quantitation of th. J Am Soc Echocardiogr. 1989;2(5):358–67.CrossRef
15.
go back to reference O'Driscoll JM, Gargallo-Fernandez P, Araco M, Perez-Lopez M, Sharma R. Baseline mitral regurgitation predicts outcome in patients referred for dobutamine stress echocardiography. Int J Cardiovasc Imaging. 2017;33(11):1711–21.CrossRef O'Driscoll JM, Gargallo-Fernandez P, Araco M, Perez-Lopez M, Sharma R. Baseline mitral regurgitation predicts outcome in patients referred for dobutamine stress echocardiography. Int J Cardiovasc Imaging. 2017;33(11):1711–21.CrossRef
16.
go back to reference Gottdiener J, Panza J, St John Sutton M, Bannon P, Kushner H, Weissman N. Testing the test: the reliability of echocardiography in the sequential assessment of valvular regurgitation. Am Heart J. 2002;144(1):115–21.CrossRef Gottdiener J, Panza J, St John Sutton M, Bannon P, Kushner H, Weissman N. Testing the test: the reliability of echocardiography in the sequential assessment of valvular regurgitation. Am Heart J. 2002;144(1):115–21.CrossRef
17.
go back to reference Ritchie J, Green D, Chrysochou T, et al. Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial. Nephrol Dial Transplant. 2016:gfw107. https://doi.org/10.1093/ndt/gfw107. Ritchie J, Green D, Chrysochou T, et al. Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial. Nephrol Dial Transplant. 2016:gfw107. https://​doi.​org/​10.​1093/​ndt/​gfw107.
18.
go back to reference Marcantoni C, Zanoli L, Rastelli S. Effect of renal artery stenting on left ventricular mass: a randomised clinical trial. Am J Kidney Dis. 2012;60(1):39–46.CrossRef Marcantoni C, Zanoli L, Rastelli S. Effect of renal artery stenting on left ventricular mass: a randomised clinical trial. Am J Kidney Dis. 2012;60(1):39–46.CrossRef
19.
go back to reference Symonides B, Chodakowska J, Januszewicz A, et al. Effects of the correction of renal artery stenosis on blood pressure, renal function and left ventricular morphology. Blood Press. 1999;8(3):141–50.CrossRef Symonides B, Chodakowska J, Januszewicz A, et al. Effects of the correction of renal artery stenosis on blood pressure, renal function and left ventricular morphology. Blood Press. 1999;8(3):141–50.CrossRef
20.
go back to reference Yoshitomi Y, Nishikimi T, Abe H, et al. Comparison of changes in cardiac structure after treatment in secondary hypertension. Hypertension. 1996;27(3 (Pt 1):319–23.CrossRef Yoshitomi Y, Nishikimi T, Abe H, et al. Comparison of changes in cardiac structure after treatment in secondary hypertension. Hypertension. 1996;27(3 (Pt 1):319–23.CrossRef
21.
go back to reference Vassallo D, Ritchie J, Green D, Chrysochou C, Kalra PA. The effect of revascularization in patients with anatomically significant atherosclerotic renovascular disease presenting with high-risk clinical features. Nephrol Dial Transpl. 2017;Epub ahead. https://doi.org/10.1093/ndt/gfx025.CrossRef Vassallo D, Ritchie J, Green D, Chrysochou C, Kalra PA. The effect of revascularization in patients with anatomically significant atherosclerotic renovascular disease presenting with high-risk clinical features. Nephrol Dial Transpl. 2017;Epub ahead. https://​doi.​org/​10.​1093/​ndt/​gfx025.CrossRef
24.
go back to reference Waagstein F, Stromblad O, Andersson B, et al. Increased exercise ejection fraction and reversed remodeling after long- term treatment with metoprolol in congestive heart failure : a randomized, stratified, double-blind , placebo-controlled trial in mild to moderate heart failure due to ischemic or. Eur J Hear Fail Fail. 2003;5(5):679–91. https://doi.org/10.1016/S1388-9842.CrossRef Waagstein F, Stromblad O, Andersson B, et al. Increased exercise ejection fraction and reversed remodeling after long- term treatment with metoprolol in congestive heart failure : a randomized, stratified, double-blind , placebo-controlled trial in mild to moderate heart failure due to ischemic or. Eur J Hear Fail Fail. 2003;5(5):679–91. https://​doi.​org/​10.​1016/​S1388-9842.CrossRef
32.
go back to reference Losito A, Errico R, Santirosi P, Lupattelli T, Scalera GB, Lupattelli L. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant. 2005;20(8):1604–9.CrossRef Losito A, Errico R, Santirosi P, Lupattelli T, Scalera GB, Lupattelli L. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant. 2005;20(8):1604–9.CrossRef
Metadata
Title
Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-study
Authors
Darren Green
Diana Vassallo
Kelly Handley
Natalie Ives
Keith Wheatley
Constantina Chrysochou
Janet Hegarty
Julian Wright
Jon Moss
Rajan K. Patel
Chris Deighan
John Webster
Peter Rowe
Sue Carr
Jenny Cross
Jamie O’Driscoll
Raj Sharma
Patrick Mark
Philip A. Kalra
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1406-y

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.